← FDA Drug Approvals (Drugs@FDA)
NEOSTIGMINE METHYLSULFATE
ANDA · Abbreviated New Drug Application (Generic) · Sponsor: AMRING PHARMS · Approved 2018-08-22
Drug application
- FDA Application #
ANDA210989- Application type
- Abbreviated New Drug Application (Generic)
- Brand name
- NEOSTIGMINE METHYLSULFATE
- Generic name
- Neostigmine Methylsulfate
- Active ingredients
- NEOSTIGMINE METHYLSULFATE
- Dosage form
- SOLUTION
- Route
- INTRAVENOUS
- Marketing status
- Prescription
- Sponsor
- AMRING PHARMS
- First approval
- 2018-08-22
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown